Cargando…

GSK3 is a metabolic checkpoint regulator in B cells

B cells predominate in a quiescent state until antigen is encountered, which results in rapid growth, proliferation and differentiation. These distinct cell states are likely accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that g...

Descripción completa

Detalles Bibliográficos
Autores principales: Jellusova, Julia, Cato, Matthew H., Apgar, John R., Ramezani-Rad, Parham, Leung, Charlotte, Chen, Cindi, Richardson, Adam D., Conner, Elaine M., Benschop, Robert J., Woodgett, James R., Rickert, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310963/
https://www.ncbi.nlm.nih.gov/pubmed/28114292
http://dx.doi.org/10.1038/ni.3664
_version_ 1782507948230049792
author Jellusova, Julia
Cato, Matthew H.
Apgar, John R.
Ramezani-Rad, Parham
Leung, Charlotte
Chen, Cindi
Richardson, Adam D.
Conner, Elaine M.
Benschop, Robert J.
Woodgett, James R.
Rickert, Robert C.
author_facet Jellusova, Julia
Cato, Matthew H.
Apgar, John R.
Ramezani-Rad, Parham
Leung, Charlotte
Chen, Cindi
Richardson, Adam D.
Conner, Elaine M.
Benschop, Robert J.
Woodgett, James R.
Rickert, Robert C.
author_sort Jellusova, Julia
collection PubMed
description B cells predominate in a quiescent state until antigen is encountered, which results in rapid growth, proliferation and differentiation. These distinct cell states are likely accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that glycogen synthase kinase 3 (GSK3) is a metabolic sensor that promotes the survival of naïve recirculating B cells by restricting cell mass accumulation. In antigen-driven responses, GSK3 was selectively required for CD40-mediated regulation of B cell size, mitochondria biogenesis, glycolysis and reactive oxygen species (ROS) production. GSK3 was required to prevent metabolic collapse and ROS-induced apoptosis when glucose became limiting, functioning in part by repressing c-Myc-dependent growth. Importantly, we found that GSK3 was required for the generation and maintenance of germinal center B cells, which require high glycolytic activity to support growth and proliferation in a hypoxic microenvironment.
format Online
Article
Text
id pubmed-5310963
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-53109632017-07-23 GSK3 is a metabolic checkpoint regulator in B cells Jellusova, Julia Cato, Matthew H. Apgar, John R. Ramezani-Rad, Parham Leung, Charlotte Chen, Cindi Richardson, Adam D. Conner, Elaine M. Benschop, Robert J. Woodgett, James R. Rickert, Robert C. Nat Immunol Article B cells predominate in a quiescent state until antigen is encountered, which results in rapid growth, proliferation and differentiation. These distinct cell states are likely accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that glycogen synthase kinase 3 (GSK3) is a metabolic sensor that promotes the survival of naïve recirculating B cells by restricting cell mass accumulation. In antigen-driven responses, GSK3 was selectively required for CD40-mediated regulation of B cell size, mitochondria biogenesis, glycolysis and reactive oxygen species (ROS) production. GSK3 was required to prevent metabolic collapse and ROS-induced apoptosis when glucose became limiting, functioning in part by repressing c-Myc-dependent growth. Importantly, we found that GSK3 was required for the generation and maintenance of germinal center B cells, which require high glycolytic activity to support growth and proliferation in a hypoxic microenvironment. 2017-01-23 2017-03 /pmc/articles/PMC5310963/ /pubmed/28114292 http://dx.doi.org/10.1038/ni.3664 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Jellusova, Julia
Cato, Matthew H.
Apgar, John R.
Ramezani-Rad, Parham
Leung, Charlotte
Chen, Cindi
Richardson, Adam D.
Conner, Elaine M.
Benschop, Robert J.
Woodgett, James R.
Rickert, Robert C.
GSK3 is a metabolic checkpoint regulator in B cells
title GSK3 is a metabolic checkpoint regulator in B cells
title_full GSK3 is a metabolic checkpoint regulator in B cells
title_fullStr GSK3 is a metabolic checkpoint regulator in B cells
title_full_unstemmed GSK3 is a metabolic checkpoint regulator in B cells
title_short GSK3 is a metabolic checkpoint regulator in B cells
title_sort gsk3 is a metabolic checkpoint regulator in b cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310963/
https://www.ncbi.nlm.nih.gov/pubmed/28114292
http://dx.doi.org/10.1038/ni.3664
work_keys_str_mv AT jellusovajulia gsk3isametaboliccheckpointregulatorinbcells
AT catomatthewh gsk3isametaboliccheckpointregulatorinbcells
AT apgarjohnr gsk3isametaboliccheckpointregulatorinbcells
AT ramezaniradparham gsk3isametaboliccheckpointregulatorinbcells
AT leungcharlotte gsk3isametaboliccheckpointregulatorinbcells
AT chencindi gsk3isametaboliccheckpointregulatorinbcells
AT richardsonadamd gsk3isametaboliccheckpointregulatorinbcells
AT connerelainem gsk3isametaboliccheckpointregulatorinbcells
AT benschoprobertj gsk3isametaboliccheckpointregulatorinbcells
AT woodgettjamesr gsk3isametaboliccheckpointregulatorinbcells
AT rickertrobertc gsk3isametaboliccheckpointregulatorinbcells